← FDA Drug Approvals (Drugs@FDA)

TASIGNA

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 2007-10-29

Drug application

FDA Application #

NDA022068

Application type

New Drug Application

Brand name

TASIGNA

Generic name

NILOTINIB

Active ingredients

NILOTINIB HYDROCHLORIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

NOVARTIS

Manufacturer

Novartis Pharmaceuticals Corporation

First approval

2007-10-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown